Bone Loss Completed Phase 4 Trials for Pamidronic acid (DB00282)

Also known as: Osteopenia / Osteopaenia

IndicationStatusPhase
DBCOND0031952 (Bone Loss)Completed4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00738257A Prospective, Multicentre, Open-label Randomised Controlled Study to Investigate the Effectiveness of Pamidronate in the Prevention of Bone Loss in de Novo Renal Transplant Patients.Treatment